🔎 Trials Near Me

Beranda › Leukemia Mieloid Akut › New York › Greenburgh

Uji klinis Leukemia Mieloid Akut di Greenburgh, NY

18 studi untuk Leukemia Mieloid Akut mencari peserta di lokasi sekitar Greenburgh (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.

Teks studi resmi (Bahasa Inggris)

Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

Menerima pesertaFase 2
  • Memorial Sloan Kettering Bergen, Montvale · 9 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 5 Okt 2026 · NCT05564390

A Study to Assess Adverse Events and How Intravenous (IV) Pivekimab Sunirine Moves Through the Body in Pediatric Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML)

Menerima pesertaFase 1
  • New York Medical College /ID# 275597, Valhalla · 5 mi jauhnya
6 Months – 17 Years · Semua jenis kelamin · Diperbarui 5 Okt 2026 · NCT07306832

Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes

Menerima pesertaFase 1
  • Memorial Sloan Kettering Bergen, Montvale · 9 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT06484062

Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)

Menerima pesertaFase 2
  • Memorial Sloan Kettering Bergen, Montvale · 9 mi jauhnya
Usia 18 hingga 59 · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT05554393

Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)

Menerima pesertaFase 2
  • Memorial Sloan Kettering Bergen, Montvale · 9 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT06672146

Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)

Menerima pesertaFase 2
  • Memorial Sloan Kettering Bergen, Montvale · 9 mi jauhnya
Usia 18 hingga 59 · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT05554406

A Study of CRD3874-SI in People With Leukemia

Menerima pesertaFase 1
  • Memorial Sloan Kettering Bergen (All Protocol Activities), Montvale · 9 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07661095

Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)

Menerima pesertaFase 2
  • Memorial Sloan Kettering Bergen, Montvale · 9 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT06317649

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

Menerima pesertaFase 3
  • New York Medical College, Valhalla · 5 mi jauhnya
6 Months – 21 Years · Semua jenis kelamin · Diperbarui 17 Sep 2026 · NCT04293562

A Study of the Combination of Ivosidenib, Azacitidine, and Venetoclax Followed by Ivosidenib Alone in People With Acute Myeloid Leukemia

Menerima pesertaFase 2
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale · 9 mi jauhnya
Usia 60 ke atas · Semua jenis kelamin · Diperbarui 17 Jul 2026 · NCT07392242

A Study of Revumenib and Mezigdomide in People With Leukemia

Menerima pesertaFase 1/2
  • Memorial Sloan Kettering Bergen (All Protocol Activities), Montvale · 9 mi jauhnya
Usia 12 ke atas · Semua jenis kelamin · Diperbarui 22 Jun 2026 · NCT07356154

A Study of CD371-YSNVZIL-18 CAR T Cells in People With Acute Myeloid Leukemia

Menerima pesertaFase 1
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale · 9 mi jauhnya
Usia 1 ke atas · Semua jenis kelamin · Diperbarui 22 Jun 2026 · NCT06017258

A Study of Gilteritinib in Combination With Ivosidenib or Enasidenib in People With Acute Myeloid Leukemia (AML)

Menerima pesertaFase 1
  • Memorial Sloan Kettering Bergen, Montvale · 9 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Jun 2026 · NCT05756777

A Study of Natural Killer Cells in Combination With Atezolizumab in People With Acute Myelogenous Leukemia

Menerima pesertaFase 1
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale · 9 mi jauhnya
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 17 Jun 2026 · NCT07011004

A Study of ADCLEC.syn1 in People With Acute Myeloid Leukemia

Menerima pesertaFase 1
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale · 9 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 10 Mar 2026 · NCT05748197

A Study of Azacitidine and Venetoclax in People With Acute Myeloid Leukemia (AML)

Menerima pesertaFase 2
  • Memorial Sloan Kettering Bergen (All Protocol Activities), Montvale · 9 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 24 Feb 2026 · NCT06773208

Metabolically Optimized, Non-cytotoxic Low Dose Weekly Decitabine/Venetoclax in MDS and AML

Menerima pesertaFase 2
  • White Plains Hospital, White Plains · 4 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 5 Jan 2026 · NCT05184842

Uji klinis Leukemia Mieloid Akut di kota lain

Studi lain di Greenburgh

Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.